Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
BRCA or HRR+ Mutated Ovarian Cancer Patients
×
Gynecologic
×
Clear all
Filters
3
NCT02476968
2022-09-10
ORZORA
AstraZeneca
Phase 4
Completed
181 enrolled
24 charts